Literature DB >> 23255933

Clinicopathological characteristics of patients with synchronous primary endometrial and ovarian cancers: A review of 43 cases.

Yuantao Liu1, Jun Li, Hongyan Jin, Ying Lu, Xin Lu.   

Abstract

Synchronous primary endometrial and ovarian cancers are uncommon. The purpose of this study was to evaluate the clinicopathological characteristics, treatment and prognosis of synchronous primary endometrial and ovarian cancers. The clinicopathological characteristics of 43 patients with synchronous primary endometrial and ovarian cancers in the Obstetrics and Gynecology Hospital of Fudan University between 1999 and 2009 were retrospectively reviewed. Our results revealed that the median age at the time of diagnosis was 51 years (range, 29-71). The common presenting symptoms were abnormal uterine bleeding (AUB, 65.12%), abdominal mass (25.58%), abdominal pain and abdominal fullness (39.53%). An elevated CA125 level was observed in the majority of patients (n=20, 76.9%). Endometrioid type accounted for 60.47% of uterine carcinomas and different pathological types, including serous adenocarcinoma, clear cell carcinoma, adenosquamous and acanthoadenocarcinoma, were also identified in synchronous primary endometrial and ovarian cancers. All patients underwent surgical intervention (hysterectomy and bilateral salpingo-oophorectomy with pelvic lymphadenectomy or debulking surgery). The 5-year survival rate was 86.05% and nine patients had recurrence (20.93%). The early stage group (FIGO stages I and II) had more favorable prognosis than the advanced stage group (FIGO stages III and IV; P<0.05). In conclusion, synchronous primary endometrial and ovarian cancers are different from either primary endometrial carcinoma or ovarian cancer and are usually identified at early stages with a good prognosis.

Entities:  

Year:  2012        PMID: 23255933      PMCID: PMC3525502          DOI: 10.3892/ol.2012.943

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  10 in total

1.  Frequent microsatellite instability in synchronous ovarian and endometrial adenocarcinoma and its usefulness for differential diagnosis.

Authors:  Eisuke Kaneki; Yoshinao Oda; Yoshihiro Ohishi; Sadafumi Tamiya; Shinya Oda; Toshio Hirakawa; Hitoo Nakano; Masazumi Tsuneyoshi
Journal:  Hum Pathol       Date:  2004-12       Impact factor: 3.466

2.  Clinicopathologic analysis of the prognostic factors in women with coexistence of endometrioid adenocarcinoma in the endometrium and ovary.

Authors:  Noriko Nishimura; Toru Hachisuga; Masatoshi Yokoyama; Tsuyoshi Iwasaka; Tatsuhiko Kawarabayashi
Journal:  J Obstet Gynaecol Res       Date:  2005-04       Impact factor: 1.730

3.  Survival and prognostic factors in patients with synchronous ovarian and endometrial cancers and endometrial cancers metastatic to the ovaries.

Authors:  A Ayhan; T Guvenal; F Coskun; M Basaran; M C Salman
Journal:  Eur J Gynaecol Oncol       Date:  2003       Impact factor: 0.196

4.  Simultaneously detected endometrial and ovarian carcinomas--a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study.

Authors:  R Zaino; C Whitney; M F Brady; K DeGeest; R A Burger; R E Buller
Journal:  Gynecol Oncol       Date:  2001-11       Impact factor: 5.482

5.  Synchronous early-stage endometrial and ovarian cancer.

Authors:  Mauro Signorelli; Robert Fruscio; Andrea Alberto Lissoni; Cecilia Pirovano; Patrizia Perego; Costantino Mangioni
Journal:  Int J Gynaecol Obstet       Date:  2008-03-17       Impact factor: 3.561

6.  Adenocarcinoma of the endometrium. Analysis of 256 cases with disease limited to the uterine corpus: treatment comparisons.

Authors:  P J Eifel; J Ross; M Hendrickson; R S Cox; R Kempson; A Martinez
Journal:  Cancer       Date:  1983-09-15       Impact factor: 6.860

7.  PTEN as a molecular marker to distinguish metastatic from primary synchronous endometrioid carcinomas of the ovary and uterus.

Authors:  Romeo Ricci; Paul Komminoth; Fridolin Bannwart; Joachim Torhorst; Edward Wight; Philipp U Heitz; Rosmarie F Caduff
Journal:  Diagn Mol Pathol       Date:  2003-06

8.  Simultaneous carcinoma of the endometrium and ovary vs endometrial carcinoma with ovarian metastases: a clinical and immunohistochemical determination.

Authors:  R Halperin; S Zehavi; E Hadas; L Habler; I Bukovsky; D Schneider
Journal:  Int J Gynecol Cancer       Date:  2003 Jan-Feb       Impact factor: 3.437

9.  Synchronous primary cancers of the endometrium and ovary.

Authors:  Y-C Chiang; C-A Chen; C-Y Huang; C-Y Hsieh; W-F Cheng
Journal:  Int J Gynecol Cancer       Date:  2007-05-15       Impact factor: 3.437

Review 10.  Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.

Authors:  Pamela T Soliman; Brian M Slomovitz; Russell R Broaddus; Charlotte C Sun; Jonathan C Oh; Patricia J Eifel; David M Gershenson; Karen H Lu
Journal:  Gynecol Oncol       Date:  2004-08       Impact factor: 5.482

  10 in total
  6 in total

1.  Hydrosalpinx as a Rare Presentation of Synchronous Ovarian and Endometrial Carcinoma - A Case Report.

Authors:  Mahjabeen Khan; Sapna Vinit Amin; Sujatha Bagepalli Srinivas; Roopa Padavagodu Shivananda; Navin Patil
Journal:  J Clin Diagn Res       Date:  2016-07-01

Review 2.  Endometriosis: pathogenesis and treatment.

Authors:  Paolo Vercellini; Paola Viganò; Edgardo Somigliana; Luigi Fedele
Journal:  Nat Rev Endocrinol       Date:  2013-12-24       Impact factor: 43.330

3.  Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome.

Authors:  Casper Reijnen; Heidi V N Küsters-Vandevelde; Marjolijn J L Ligtenberg; Johan Bulten; Marloes Oosterwegel; Marc P L M Snijders; Sanne Sweegers; Joanne A de Hullu; Maria C Vos; Anneke A M van der Wurff; Anne M van Altena; Astrid Eijkelenboom; Johanna M A Pijnenborg
Journal:  Int J Cancer       Date:  2020-02-18       Impact factor: 7.396

4.  Synchronous primary endometrium and ovarian carcinoma: A case report.

Authors:  Yasoda Rijal; Suraj Shrestha; Laxmi Bogati; Priyanka Regmi; Sushi Shrestha; Prabesh Luitel; Chandra Narayan Yadav; Bishal Khaniya; Suvana Maskey
Journal:  Clin Case Rep       Date:  2022-10-08

Review 5.  Potential for Mitochondrial DNA Sequencing in the Differential Diagnosis of Gynaecological Malignancies.

Authors:  Anna Myriam Perrone; Giulia Girolimetti; Martina Procaccini; Lorena Marchio; Alessandra Livi; Giulia Borghese; Anna Maria Porcelli; Pierandrea De Iaco; Giuseppe Gasparre
Journal:  Int J Mol Sci       Date:  2018-07-13       Impact factor: 5.923

6.  How to manage synchronous endometrial and ovarian cancer patients?

Authors:  Wonkyo Shin; Sang-Yoon Park; Sokbom Kang; Myong Cheol Lim; Sang-Soo Seo
Journal:  BMC Cancer       Date:  2021-05-01       Impact factor: 4.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.